Following the ADA update of the bacillus Calmette-Guerin (BCG) vaccine as a treatment for type 1 diabetes (T1D) earlier this month, leading data and analytics company GlobalData notes that BCG is well positioned as a repurposed drug to out-compete more expensive pipeline immunotherapy options if further studies continue to demonstrate similar efficacy results. Samisha Khangaonkar, […]

Artificial intelligence (AI) and big data will play a major role in optimizing pharmaceutical drug discovery and development process, as indicated by 24% and 25% of global healthcare industry professionals, respectively 23% of the surveyed healthcare industry professionals confirmed that their companies were currently using in AI to enhance drug discovery and development process with […]

Corticosteroids are typically the first line of therapy for most patients with uveitis as these drugs are very effective and have anti-inflammatory effects. However, as corticosteroids are associated with the development of cataracts and changes in intraocular pressures, it is becoming increasingly common for other immunosuppressants such as antimetabolites and calcineurin inhibitors to be prescribed […]

Topical Janus kinase (JAK) inhibitors are becoming a major force in the atopic dermatitis (AD) space. An increasing number of JAK agents are filling the early and late-stage pipeline, says GlobalData. The leading data and analytics company notes that, of the 98 pipeline agents, eight are JAKs – with six of these being topical formulations. […]

Following the news that cases of COVID-19 due to the Delta variant in the UK have increased, despite record numbers of people being vaccinated; Emily Martyn, Infectious Disease Analyst at GlobalData, a leading data and analytics company, offers her view: “While the UK Vaccine Taskforce should be applauded for its sterling work in ensuring 83.3%* […]